Effect of angiotensin ii on inflammation pathways in human primary bone cell cultures in otosclerosis

Audiology and Neurotology

Volumn 17, Issue 3, 2012, Pages 169-178

  Rudić, Milan ^a,b   Nguyen, Christine ^a   Nguyen, Yann ^a   Milković, Lidija ^c   Arković, Neven ^c   Sterkers, Olivier ^a,b   Ferrary, Evelyne ^a,b   Bozorg Grayeli, Alexis ^a,b  

^a GH Pitié Salpêtrière Bâtiment Castaigne   (France)

^b BEAUJON HOSPITAL   (France)

^c RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Angiotensin II; Bone dystrophy; Bone remodeling; Hearing loss; Inflammation

Indexed keywords

ANGIOTENSIN II; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; FEMALE; HUMAN; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; OSTEOCYTE; OTOSCLEROSIS; PATHOLOGY; SIGNAL TRANSDUCTION; STAPES;

ADULT; ANGIOTENSIN II; CELLS, CULTURED; CHEMOKINE CCL3; CHEMOKINE CXCL10; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-1; MALE; MIDDLE AGED; OSTEOCYTES; OTOSCLEROSIS; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; STAPES; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 84856202683     PISSN: 14203030     EISSN: 14219700     Source Type: Journal    
DOI: 10.1159/000335098     Document Type: Article

References (22)

1. Asaba Y, Ito M, Fumoto T, Watanabe K, Fukuhara R, Takeshita S, Nimura Y, Ishida J, Fukamizu A, Ikeda K: Activation of renin-angiotensin system induces osteoporosis independently of hypertension. J Bone Miner Res 2009; 24: 241-250.
2. Bozorg Grayeli A, Sterkers O, Roulleau P, Elbaz P, Ferrary E, Silve C: Parathyroid hormoneparathyroid hormone-related peptide receptor expression and function in otosclerosis. Am J Physiol 1999; 277:E1005-E1012. (Pubitemid 30045993)
3. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thyocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159. (Pubitemid 17064313)
4. Dufour JH, Dziejman M, Liu MT, Leeng JH, Lane TE, Luster AD: IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 2002; 168: 3195-31204.
5. Fanó G, Venti-Donti G, Belia S, Paludetti G, Antonica A, Donti E, Maurizi M: PTH induces modification of transductive events in otosclerotic bone cell cultures. Cell Biochem Funct 1993; 11: 257-261. (Pubitemid 23342140)
6. Guo RW, Yang LX, Li MQ, Liu B, Wang XM: Angiotensin II induces NF-B activation in HUVEC via the p38MAPK pathway. Peptides 2006; 27: 3269-3275. (Pubitemid 44738184)
7. Imauchi Y, Jeunemaitre X, Boussion M, Ferrary E, Sterkers O, Bozorg Grayeli A: Relation between renin-angiotensin-aldosterone system and otosclerosis: a genetic association and in vitro study. Otol Neurotol 2008; 29: 295-301.
8. Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H: Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2011; 7: 33-42.
9. Lamperter S, Kling L, Schrader M, Ziegler R, Pfeilschifter J: Effects of angiotensin II on bone cells in vitro. J Cell Physiol 1998; 175: 89-98. (Pubitemid 28101975)
10. Locksley RM, Killeen N, Lenardo MJ: The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001; 104: 487-501. (Pubitemid 32201945)
11. McPhee JR, Van der Water TR, Gordon MA: Otosclerosis. Correlation and clinical incidence and abnormal TIMP gene expression. Ann NY Acad Sci 1991; 630: 319-321.
12. Menger DJ, Tange RA: The etiology of otosclerosis: a review of the literature. Clin Otolaryngol 2003; 28: 112-120.
13. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765. (Pubitemid 32368050)
14. Roland PS, Samy RN: Otosclerosis; in Bailey J, Johnson JT, Newlands SD (eds): Head and Neck Surgery-Otolaryngology. Philadelphia, Lippincott Williams and Wilkins, 2006, pp 2126-2137.
15. Schaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt LM: BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 2000; 13: 199-212.
16. Schrier R, Durr J: Pregnancy: an overfill or underfill state. Am J Kidney Dis 1987; 9: 284-289. (Pubitemid 17089634)
17. Schroder K, Hertzog PJ, Ravasi T, Hume DA: Interferon gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004; 75: 163-189. (Pubitemid 38174573)
18. Sherry B, Tekamp-Olson P, Gallegos C, Bauer D, Davatelis G, Wolpe SD, Masiarz F, Coit D, Cerami A: Resolution of the two components of macrophage inflammatory protein 1, and cloning and characterization of one of those components, macrophage inflammatory protein 1 beta. J Exp Med 1988; 168: 2251-2259. (Pubitemid 19020903)
19. Stankovic KM, Adachi O, Tsuji K, Kristiansen AG, Adams JC, Rosen V, McKenna MJ: Difference in gene expression between the otic capsule and other bones. Hear Res 2010; 265: 83-89.
20. Sziklai I, Batta TJ, Karosi T: Otosclerosis: an organ-specific inflammatory disease with sensorineural hearing loss. Eur Arch Otorhinolaryngol 2009; 266: 1711-1718.
21. Woo KM, Kim HM, Ko JS: Macrophage colonystimulating factor promotes the survival of osteoclast precursors by up-regulating Bcl-X(L). Exp Mol Med 2002; 34: 340-346. (Pubitemid 36019389)
22. Yang YC, Yin T: Interleukin-11 and its receptor. Biofactors 1993; 4: 15-21. (Pubitemid 23032879)